Phones join war on HIV, syphilis

06 February 2015 - 02:33 By Reuters
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now
Experts hope a new lab-on-a-chip device could be a helpful tool to help remote or underserved populations.
Experts hope a new lab-on-a-chip device could be a helpful tool to help remote or underserved populations.
Image: AFP Relaxnews ©Denys Prykhodov/shutterstock.com

A device that plugs into the audio jack of a smartphone and costs less than R400 was nearly as effective as far more costly diagnostic blood testing equipment in identifying antibodies for HIV and syphilis in a pilot study in Africa, US researchers said this week.

The mobile lab device, known as a dongle, costs $34 (R384) to make, compared with over $18000 for the gold-standard diagnostic equipment.

In a pilot study, the device performed all the mechanical, optical and electronic functions of a lab-based blood test in 15 minutes, using just the power drawn from the smartphone.

It was developed by a team led by Samuel Sia, a biomedical engineering professor at Columbia University in New York.

To test its effectiveness, healthcare workers in Rwanda used the tool to do finger-prick blood tests on 96 patients, including women who were at risk of passing sexually transmitted diseases to their unborn children.

The team compared the results with standard enzyme-linked immunosorbent assay, or Elisa, testing, and found that the results were nearly as accurate. The test has a sensitivity of 92% to 100%, a measurement of how often the tests accurately identified the target antibodies, and it had a specificity of 79% to 100%, an indicator of how well the test did at ruling out people who were not infected.

"Our work shows that a full laboratory-quality immunoassay can be run on a smartphone accessory," Sia said.

The researchers estimate that, with syphilis, a test with only 70% to 80% sensitivity, deaths could be reduced tenfold compared with a 100% accurate lab-based test because the non-lab test would increase syphilis diagnosis.

The study was backed by a grant from the Gates Foundation and several other funders and published on Wednesday in Science Translational Medicine.

The researchers are planning a larger-scale clinical trial with the goal of winning approval by the World Health Organisation for use in developing countries.

subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now